Showing results (1561-1570 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|April 17, 2021
Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trialJuliana Rachel Hoeper, Jan Zeidler, Sara Eileen Meyer, et al.
RMD Open|November 22, 2019
Development of generic core competences of health professionals in rheumatology: a systematic literature review informing the 2018 EULAR recommendationsGeorge E Fragoulis, Lisa Edelaar, Theodora P M Vliet Vlieland, et al.
RMD Open|December 5, 2019
Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort studyKarin Bengtsson, Eva Klingberg, Anna Deminger, et al.
RMD Open|December 5, 2019
Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapiesAnnaCarin Horne, Bénédicte Delcoigne, Karin Palmblad, et al.
RMD Open|November 2, 2019
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world settingHuifang Liang, Raghava Danwada, Dianlin Guo, et al.
RMD Open|November 2, 2019
Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortalityFernando Pérez Ruiz, Pascal Richette, Austin G Stack, et al.
RMD Open|November 2, 2019
Canada-Denmark MRI scoring system of the spine in patients with axial spondyloarthritis: updated definitions, scoring rules and inter-reader reliability in a multiple reader settingSimon Krabbe, Mikkel Østergaard, Susanne J Pedersen, et al.
RMD Open|February 5, 2019
Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological careDenis Poddubnyy, Johanna Callhoff, Inge Spiller, et al.
RMD Open|February 5, 2019
Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritisJanneke J de Winter, Jacqueline E Paramarta, Henriëtte M de Jong, et al.
RMD Open|February 5, 2019
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugsVibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, et al.
Pageof 192